However, although the in vivo P4HA3 silencing by intraperitonealinjection with AAV counteracts HFD-induced obesity and improves insulin resistance,we could not conclude whether the effects come directly from its influence inadipose tissues or liver tissues. The gene discussed is INS; the disease is Obesity.